Enanta Pharm (ENTA) Narrows Q2 Loss
Tweet
Share
E-mailGet Alerts ENTA Hot Sheet
Join SI Premium – FREE
Enanta Pharm (NASDAQ: ENTA) reported Q2 EPS of ($0.28), versus ($2.28) reported last year. Revenue for the quarter came in at $2.2 million, versus $1.2 million reported last year.
For earnings history and earnings-related data on Enanta Pharm (ENTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Stardust Power (SDST) Tops Q2 EPS by 1c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
